1. Abdallah M.S., Madi A.F., Rana M.A. The Best Use of Systemic Corticosteroids in the Intensive Care Units, Review // J. Steroids Horm. Sci. 2015. Vol. 6. N 149. doi:10.4172/2157-7536.1000149
2. Agyeman A.A., Chin K.L., Landersdorfer C.B. et al. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis // Mayo Clinic Proceedings. 2020. Vol. 95, Issue 8. P. 1621-1631.
3. Aygün i., Kaya M., Alhajj R. Identifying side effects of commonly used drugs in the treatment of Covid 19 // Sci. Rep. 2020. Vol. 10, N 1. P. 21508. https://doi.org/10.1038/s41598-020-78697-1
4. Czock D., Keller F., Rasche F.M. et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids // Clin. Pharmacokinet. 2005. Vol. 44. P. 61-98. https://doi.
org/10.2165/00003088-200544010-00003
5. Fields T.R. Steroid Side Effects: How to Reduce Drug Side Effects of Corticosteroids. https://www. hss.edu/conditions_steroid-side-effects-how-to-reduce-corticosteroid-side-effects.asp
6. Gao C., Cai Y., Zhang K. et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study // Eur. Heart J. 2020, Jun. 7. Vol. 41, N 22. P. 2058-2066. doi: 10.1093/eurheartj/ehaa433
7. Greenhalgh T., Knight M., A`Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care // BMJ. 2020. Vol. 370. m3026. doi:10.1136/bmj.m3026
8. Gupta A., Madhavan M.V., Sehgal K. et al. Extrapulmonary manifestations of COVID-19 // Nat. Med. 2020. Vol. 26. P. 1017-1032. https://doi.org/10.1038/s41591-020-0968-3
9. Hojyo S., Uchida M., Tanaka K. et al. How COVID-19 induces cytokine storm with high mortality // Inflamm. Regener. 2020. Vol. 40. P. 37. https://doi.org/10.1186/s41232-020-00146-3